304 related articles for article (PubMed ID: 10893583)
1. The role of volume weighted mean nuclear volume in predicting the prognosis of patients with primary transitional cell carcinoma of the upper urinary tract: a report of 102 new cases.
Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
J Urol; 2000 Aug; 164(2):352-5. PubMed ID: 10893583
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic criteria in patients with renal pelvic and ureteral cancers--clinical value of volume weighted mean nuclear volume].
Aoyama T; Fujikawa K; Sasaki M
Hinyokika Kiyo; 1996 Nov; 42(11):841-5. PubMed ID: 8973933
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract.
Hong B; Park S; Hong JH; Kim CS; Ro JY; Ahn H
Urology; 2005 Apr; 65(4):692-6. PubMed ID: 15833510
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.
Akdogan B; Dogan HS; Eskicorapci SY; Sahin A; Erkan I; Ozen H
J Urol; 2006 Jul; 176(1):48-52. PubMed ID: 16753365
[TBL] [Abstract][Full Text] [Related]
5. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma.
Wu CF; Chang PL; Chen CS; Chuang CK; Weng HH; Pang ST
J Urol; 2006 Aug; 176(2):477-81. PubMed ID: 16813872
[TBL] [Abstract][Full Text] [Related]
6. Role of volume weighted mean nuclear volume for predicting disease outcome in patients with renal cell carcinoma.
Fujikawa K; Sasaki M; Aoyama T; Itoh T
J Urol; 1997 Apr; 157(4):1237-41. PubMed ID: 9120910
[TBL] [Abstract][Full Text] [Related]
7. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of primary testicular seminoma: a report on 57 new cases.
Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
Cancer Res; 2000 Apr; 60(8):2152-4. PubMed ID: 10786678
[TBL] [Abstract][Full Text] [Related]
9. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ
Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
[TBL] [Abstract][Full Text] [Related]
10. Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis.
Miyata Y; Kanda S; Ohba K; Nomata K; Eguchi J; Hayashida Y; Kanetake H
J Urol; 2006 Jul; 176(1):348-53. PubMed ID: 16753442
[TBL] [Abstract][Full Text] [Related]
11. Volume-weighted mean nuclear volume as a prognostic factor in renal cell carcinoma.
Soda T; Fujikawa K; Ito T; Sasaki M; Nishio Y; Miyakawa M
Lab Invest; 1999 Jul; 79(7):859-67. PubMed ID: 10418826
[TBL] [Abstract][Full Text] [Related]
12. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.
Wu CF; Pang ST; Chen CS; Chuang CK; Chen Y; Lin PY
J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129
[TBL] [Abstract][Full Text] [Related]
13. [Urothelial carcinoma of the upper urinary tract. Survival and prognostic factors].
Arrizabalaga Moreno M; Díez Rodríguez JM; García González JI; Esteban Arteaga R; Navarro Sebastián J; Castro Pita M; Mora Durban M; Paniagua Andrés P
Arch Esp Urol; 1998 Apr; 51(3):243-51. PubMed ID: 9622915
[TBL] [Abstract][Full Text] [Related]
14. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?
Brown GA; Busby JE; Wood CG; Pisters LL; Dinney CP; Swanson DA; Grossman HB; Pettaway CA; Munsell MF; Kamat AM; Matin SF
BJU Int; 2006 Dec; 98(6):1176-80. PubMed ID: 17125474
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract.
Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
Urology; 2005 Feb; 65(2):279-83. PubMed ID: 15708038
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
[TBL] [Abstract][Full Text] [Related]
17. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
[TBL] [Abstract][Full Text] [Related]
18. Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival.
Miyata Y; Kanda S; Nomata K; Hayashida Y; Kanetake H
Urology; 2004 Mar; 63(3):602-8. PubMed ID: 15028476
[TBL] [Abstract][Full Text] [Related]
19. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?
Maulard-Durdux C; Dufour B; Hennequin C; Chrétien Y; Vignes B; Droz D; Delanian S; Housset M
J Urol; 1996 Jan; 155(1):115-7. PubMed ID: 7490805
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter.
Kamijima S; Tobe T; Suyama T; Ueda T; Igarashi T; Ichikawa T; Ito H
Int J Urol; 2005 Nov; 12(11):941-7. PubMed ID: 16351648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
